Skip to main content
SpringerLink
Log in

Energy Generating Pathways and the Tumor Suppressor p53

  • Chapter
  • First Online:
Mitochondria and Cancer

  • 1244 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Arora, K. K. and Pedersen, P. L. 1988. Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP. J. Biol. Chem. 263:17422–17428.

    CAS  PubMed  Google Scholar 

  • Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N., Nakano, K., Bartrons, R., Gottlieb, E., Vousden, K. H. 2006. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126:107–120.

    Article  CAS  PubMed  Google Scholar 

  • Board, M., Colquhoun, A., Newsholme, E. A. 1995. High Km glucose-phosphorylating (glucokinase) activities in a range of tumor cell lines and inhibition of rates of tumor growth by the specific enzyme inhibitor mannoheptulose. Cancer Res. 55:3278–3285.

    CAS  PubMed  Google Scholar 

  • Boren, J., Cascante, M., Marin, S., Comín-Anduix, B., Centelles, J. J., Lim, S., Bassilian, S., Ahmed, S., Lee, W. N., Boros, L. G. 2001. Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. J. Biol. Chem. 276:37747–37753.

    CAS  PubMed  Google Scholar 

  • Bradshaw, P. C. and Pfeiffer, D. R. 2006. Loss of NAD(H) from swollen yeast mitochondria. BMC Biochem. 7:3.

    Article  PubMed  CAS  Google Scholar 

  • Briasoulis, E., Pavlidis, N., Terret, C., Bauer, J., Fiedler, W., Schoffski, P., Raoul, J. L., Hess, D., Selvais, R., Lacombe, D., Bachmann, P., Fumoleau, P. 2003. Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group. Eur. J. Cancer 39:2334–2340.

    Article  CAS  PubMed  Google Scholar 

  • Bryson, J. M., Coy, P. E., Gottlob, K., Hay, N., Robey, R. B. 2002. Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death. J. Biol. Chem. 277:11392–11400.

    Article  CAS  PubMed  Google Scholar 

  • Capaldi, R. A. 1990. Structure and function of cytochrome c oxidase. Annu. Rev. Biochem. 59:569–596.

    Article  CAS  PubMed  Google Scholar 

  • Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., Green, D. R. 2004. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303:1010–1014.

    Article  CAS  PubMed  Google Scholar 

  • Corcoran, C. A., Huang, Y. and Sheikh, M. S. 2004. The p53 paddy wagon: COP1, Pirh2 and MDM2 are found resisting apoptosis and growth arrest. Cancer Biol. Ther. 3:721–725.

    Article  CAS  PubMed  Google Scholar 

  • Craig, A. L., Chrystal, J. A., Fraser, J. A., Sphyris, N., Lin, Y., Harrison, B. J., Scott, M. T., Dornreiter, I., Hupp, T. R. 2007. The MDM2 ubiquitination signal in the DNA-binding domain of p53 forms a docking site for calcium calmodulin kinase superfamily members. Mol. Cell. Biol. 27:3542–3555.

    Article  CAS  PubMed  Google Scholar 

  • Di Cosimo, S., Ferretti, G., Papaldo, P., Carlini, P., Fabi, A., Cognetti, F. 2003. Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors. Drugs Today (Barc) 39:157–174

    Article  CAS  Google Scholar 

  • Durany, N., Joseph, J., Campo, E., Molina, R., Carreras, J. 1997a. Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and enolase activity and isoenzymes in lung, colon and liver carcinomas. Br. J. Cancer 75:969–977.

    CAS  Google Scholar 

  • Durany, N., Joseph, J., Cruz-Sanchez, F. F., Carreras, J. 1997b. Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and creatine kinase activity and isoenzymes in human brain tumours. Br. J. Cancer 76:1139–1149.

    CAS  Google Scholar 

  • Durany, N., Joseph, J., Jimenez, O. M., Climent, F., Fernandez, P. L., Rivera, F., Carreras, J. 2000. Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma. Br. J. Cancer 82:20–7.

    Article  CAS  PubMed  Google Scholar 

  • Erster, S. and Moll, U. M. 2005. Stress-induced p53 runs a transcription-independent death program. Biochem. Biophys. Res. Commun. 331:843–850.

    Article  CAS  PubMed  Google Scholar 

  • Fang, L., Li, G., Liu, G., Lee, S. W., Aaronson, S. A. 2001. p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. EMBO J. 20:1931–1939.

    Article  CAS  PubMed  Google Scholar 

  • Feng, Z., Hu, W., de Stanchina, E., Teresky, A. K., Jin, S., Lowe, S., Levine, A. J. 2007. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res. 67:3043–3053.

    Article  CAS  PubMed  Google Scholar 

  • Floridi, A., Paggi, M. G., Marcante, M. L., Silvestrini, B., Caputo, A., De Martino, C. 1981. Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells. J. Natl. Cancer Inst. 66:497–499.

    CAS  PubMed  Google Scholar 

  • Floridi, A., Paggi, M. G., D’Atri, S., De Martino, C., Marcante, M. L., Silvestrini, B., Caputo, A. 1981. Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells. Cancer Res. 41:4661–4666.

    CAS  PubMed  Google Scholar 

  • Forte, M., Adelsberger-Mangan, D., and Colombini, M. 1987. Purification and characterization of the voltage-dependent anion channel from the outer mitochondrial membrane of yeast. J. Membr. Biol. 99:65–72.

    Article  CAS  PubMed  Google Scholar 

  • Gatenby, R. A. and Gillies, R. J. 2004. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4:891–899.

    Article  CAS  Google Scholar 

  • Giaccone, G., Smit, E. F., de Jonge, M., Dansin, E., Briasoulis, E., Ardizzoni, A., Douillard, J. Y., Spaeth, D., Lacombe, D., Baron, B., Bachmann, P., Fumoleau, P.; 2004. Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group. Eur. J. Cancer 40:667–672.EORTC-New Drug Development Group.

    Article  CAS  PubMed  Google Scholar 

  • Glass-Marmor, L., Beitner, R. 1997. Detachment of glycolytic enzymes from cytoskeleton of melanoma cells induced by calmodulin antagonists. Eur. J. Pharmacol. 328:241–8.

    Article  CAS  PubMed  Google Scholar 

  • Gottschalk, S., Anderson, N., Hainz, C., Eckhardt, S. G., Serkova, N. J. 2004. Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells. Clin. Cancer Res. 10:6661–6668.

    Article  CAS  PubMed  Google Scholar 

  • Herceg, Z. and Wang, Z. Q. 2001. Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death. Mutat. Res. 477:97–110.

    CAS  PubMed  Google Scholar 

  • Horng, Y. C., Leary, S. C., Cobine, P. A., Young, F. B., George, G. N., Shoubridge, E. A., Winge, D. R. 2005. Human Sco1 and Sco2 function as copper-binding proteins. J. Biol. Chem. 280:34113–34122.

    Article  CAS  PubMed  Google Scholar 

  • Imamura, K., Ogura, T., Kishimoto, A., Kaminishi, M., Esumi, H. 2001. Cell cycle regulation via p53 phosphorylation by a 5′-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochem. Biophys. Res. Commun. 287:562–567.

    Article  CAS  PubMed  Google Scholar 

  • Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., Thompson, C. B. 2005. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 18:283–293.

    Article  CAS  PubMed  Google Scholar 

  • Kang, H. T. and Hwang, E. S. 2006. 2-Deoxyglucose: an anticancer and antiviral therapeutic, but not any more a low glucose mimetic. Life Sci. 78:1392–1399.

    Article  CAS  PubMed  Google Scholar 

  • Karuman, P., Gozani, O., Odze, R. D., Zhou, X. C., Zhu, H., Shaw, R., Brien, T. P., Bozzuto, C. D., Ooi, D., Cantley, L. C., Yuan, J. 2001. The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol. Cell 7:1307–1319.

    Article  CAS  PubMed  Google Scholar 

  • Katajisto, P., Vallenius, T., Vaahtomeri, K., Ekman, N., Udd, L., Tiainen, M., Makela, T. P. 2007. The LKB1 tumor suppressor kinase in human disease. Biochim. Biophys. Acta. 1775:63–75.

    CAS  PubMed  Google Scholar 

  • Khalimonchuk, O. and Rodel, G. 2005. Biogenesis of cytochrome c oxidase. Mitochondrion 5:363–388.

    Article  CAS  PubMed  Google Scholar 

  • Kondoh, H., Lleonart, M. E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., Beach, D. 2005. Glycolytic enzymes can modulate cellular life span. Cancer Res. 65:177–185.

    CAS  PubMed  Google Scholar 

  • Lavin, M. F. and Gueven, N. 2006. The complexity of p53 stabilization and activation. Cell Death Differ. 13:941–950.

    Article  CAS  PubMed  Google Scholar 

  • Leu, J. I., Dumont, P., Hafey, M., Murphy, M. E., George, D. L. 2004. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat. Cell Biol. 6:443–450.

    Article  CAS  PubMed  Google Scholar 

  • Li, P. F., Dietz, R. and von Harsdorf, R. 1999. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J. 18:6027–6036.

    Article  CAS  PubMed  Google Scholar 

  • Lim, Y. P., Lim, T. T., Chan, Y. L., Song, A. C., Yeo, B. H., Vojtesek, B., Coomber, D., Rajagopal, G., Lane, D. 2007. The p53 knowledgebase: an integrated information resource for p53 research. Oncogene 26:1517–1521.

    Article  CAS  PubMed  Google Scholar 

  • Ludes-Meyers, J. H., Subler, M. A., Shivakumar, C. V., Munoz, R. M., Jiang, P., Bigger, J. E., Brown, D. R., Deb, S. P., Deb, S. 1996. Transcriptional activation of the human epidermal growth factor receptor promoter by human p53. Mol. Cell. Biol. 16:6009–6019.

    CAS  PubMed  Google Scholar 

  • Luo, J., Nikolaev, A. Y., Imai, S., Chen, D., Su, F., Shiloh, A., Guarente, L., Gu, W. 2001. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107:137–148.

    Article  CAS  PubMed  Google Scholar 

  • Luo, Z., Saha, A. K., Xiang, X., Ruderman, N. B. 2005. AMPK, the metabolic syndrome and cancer. Trends Pharmacol. Sci. 26:69–76.

    Article  CAS  PubMed  Google Scholar 

  • Macheda, M. L., Rogers, S. and Best, J. D. 2005. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J. Cell Physiol. 202:654–662.

    Article  CAS  PubMed  Google Scholar 

  • Majewski, N., Nogueira, V., Robey, R. B., Hay, N. 2004a. Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases. Mol. Cell. Biol. 24:730–740.

    Article  CAS  Google Scholar 

  • Majewski, N., Nogueira, V., Bhaskar, P., Coy, P. E., Skeen, J. E., Gottlob, K., Chandel, N. S., Thompson, C. B., Robey, R. B., Hay, N. 2004b. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol. Cell 16:819–830.

    Article  CAS  Google Scholar 

  • Mathupala, S. P., Rempel, A. and Pedersen, P. L. 1997a. Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase. J. Bioenerg. Biomembr. 29:339–343.

    Article  CAS  Google Scholar 

  • Mathupala, S. P., Heese, C. and Pedersen, P. L. 1997b. Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J. Biol. Chem. 272:22776–22780.

    Article  CAS  Google Scholar 

  • Mathupala, S. P., Ko, Y. H. and Pedersen, P. L. 2006. Hexokinase II: cancer’s double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 25:4777–4786.

    Article  CAS  PubMed  Google Scholar 

  • Matoba, S., Kang, J. G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., Hwang, P. M. 2006. p53 regulates mitochondrial respiration. Science 312:1650–1653.

    Article  CAS  PubMed  Google Scholar 

  • McGarrity, T. J. and Amos, C. 2006. Peutz-Jeghers syndrome: clinicopathology and molecular alterations. Cell. Mol. Life Sci. 63:2135–2144.

    Article  CAS  PubMed  Google Scholar 

  • McLure, K. G., Takagi, M. and Kastan, M. B. 2004. NAD+. modulates p53 DNA binding specificity and function Mol. Cell. Biol. 24:9958–9967.

    Article  CAS  PubMed  Google Scholar 

  • Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., Moll, U. M. 2003. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 11:577–590.

    Article  CAS  PubMed  Google Scholar 

  • Mohanti, B. K., Rath, G. K., Anantha, N., Kannan, V., Das, B. S., Chandramouli, B. A., Banerjee, A. K., Das, S., Jena, A., Ravichandran, R., Sahi, U. P., Kumar, R., Kapoor, N., Kalia, V. K., Dwarakanath, B. S., Jain, V. 1996. Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. Int. J. Radiat. Oncol. Biol. Phys. 35:103–111.

    CAS  PubMed  Google Scholar 

  • Nakashima, R. A., Mangan, P. S., Colombini, M., Pedersen, P. L. 1986. Hexokinase receptor complex in hepatoma mitochondria: evidence fromN,N'-dicyclohexylcarbodiimide-labeling studies for the involvement of the pore-forming protein VDAC. Biochemistry 25:1015–1021.

    Article  CAS  PubMed  Google Scholar 

  • Oda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Tamai, K., Tokino, T., Nakamura, Y., Taya, Y. 2000. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102:849–862.

    Article  CAS  PubMed  Google Scholar 

  • Okamura, S., Ng, C. C., Koyama, K., Takei, Y., Arakawa, H., Monden, M., Nakamura, Y. 1999. Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system. Oncol. Res. 11:281–285.

    CAS  PubMed  Google Scholar 

  • Okar, D. A., Manzano, A., Navarro-Sabate, A., Riera, L., Bartrons, R., Lange, A. J. 2001. PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem. Sci. 26:30–35.

    Article  CAS  PubMed  Google Scholar 

  • Oren, M. 2003. Decision making by p53: life, death and cancer. Cell Death Differ. 10:431–442.

    Article  CAS  PubMed  Google Scholar 

  • Okorokov, A. L. and Milner, J. 1999. An ATP/ADP-dependent molecular switch regulates the stability of p53-DNA complexes. Mol. Cell. Biol. 19:7501–7510.

    CAS  PubMed  Google Scholar 

  • Ortega-Camarillo, C., Guzman-Grenfell, A. M., Garcia-Macedo, R., Rosales-Torres, A. M., Avalos-Rodriguez, A., Duran-Reyes, G., Medina-Navarro, R., Cruz, M., Diaz-Flores, M., Kumate, J. 2006. Hyperglycemia induces apoptosis and p53 mobilization to mitochondria in RINm5F cells. Mol. Cell. Biochem. 281:163–171.

    Article  CAS  PubMed  Google Scholar 

  • Parry, D. M. and Pedersen, P. L. 1983. Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumor. Evidence for an outer mitochondrial membrane location. J. Biol. Chem. 258:10904–10912.

    CAS  PubMed  Google Scholar 

  • Pastorino, J. G., Shulga, N. and Hoek, J. B. 2002. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J. Biol. Chem. 277:7610–7618.

    Article  CAS  PubMed  Google Scholar 

  • Pelicano, H., Martin, D. S., Xu, R. H., Huang, P. 2006. Glycolysis inhibition for anticancer treatment. Oncogene 25:4633–4646.

    Article  CAS  PubMed  Google Scholar 

  • Penso, J. and Beitner, R. 1998. Clotrimazole and bifonazole detach hexokinase from mitochondria of melanoma cells. Eur. J. Pharmacol. 342:113–117.

    Article  CAS  PubMed  Google Scholar 

  • Perfettini, J. L., Kroemer, R. T. and Kroemer, G. 2004. Fatal liaisons of p53 with Bax and Bak. Nat. Cell Biol. 6:386–388.

    Article  CAS  PubMed  Google Scholar 

  • Petitjean, A., Achatz, M. I., Borresen-Dale, A. L., Hainaut, P., Olivier, M. 2007. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 26:2157–2165.

    Article  CAS  PubMed  Google Scholar 

  • Prives, C. and Hall, P. A. 1999. The p53 pathway. J. Pathol. 187:112–126.

    Article  CAS  PubMed  Google Scholar 

  • Royds, J. A. and Iacopetta, B. 2006. p53 and disease: when the guardian angel fails. Cell Death. Differ. 13:1017–1026.

    Article  CAS  PubMed  Google Scholar 

  • Ruiz-Lozano, P., Hixon, M. L., Wagner, M. W., Flores, A. I., Ikawa, S., Baldwin, A. S., Jr.Chien, K. R., Gualberto, A. 1999. p53 is a transcriptional activator of the muscle-specific phosphoglycerate mutase gene and contributes in vivo to the control of its cardiac expression. Cell Growth Differ. 10:295–306.

    CAS  PubMed  Google Scholar 

  • Rustin, P., Parfait, B., Chretien, D., Bourgeron, T., Djouadi, F., Bastin, J., Rotig, A., Munnich, A. 1996. Fluxes of nicotinamide adenine dinucleotides through mitochondrial membranes in human cultured cells. J. Biol. Chem. 271:14785–14790.

    Article  CAS  PubMed  Google Scholar 

  • Sanchez-Cespedes, M. 2007. A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene 26(57):7825–7832.

    Article  CAS  Google Scholar 

  • Schwartzenberg-Bar-Yoseph, F., Armoni, M. and Karnieli, E. 2004. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 64:2627–2633.

    Article  CAS  PubMed  Google Scholar 

  • Seker, H., Bertram, B., Bürkle, A., Kaina, B., Pohl, J., Koepsell, H., Wiesser, M. 2000. Mechanistic aspects of the cytotoxic activity of glufosfamide, a new tumour therapeutic agent. Br. J. Cancer 82:629–634.

    Article  CAS  PubMed  Google Scholar 

  • Selivanova, G. and Wiman, K. G. 2007. Reactivation of mutant p53: molecular mechanisms and therapeutic potential. Oncogene 26:2243–2254.

    Article  CAS  PubMed  Google Scholar 

  • Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., Cantley, L. C. 2004. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. USA 101:3329–3335.

    Article  CAS  PubMed  Google Scholar 

  • Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S. H., Bardeesy, N., Depinho, R. A., Montminy, M., Cantley, L. C. 2005. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310:1642–1646.

    Article  CAS  PubMed  Google Scholar 

  • Shoubridge, E. A. 2001. Cytochrome c oxidase deficiency. Am. J. Med. Genet. 106:46–52.

    Article  CAS  PubMed  Google Scholar 

  • Singh, D., Banerji, A. K., Dwarakanath, B. S., Tripathi, R. P., Gupta, J. P., Mathew, T. L., Ravindranath, T., Jain, V. 2005. Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme. Strahlenther Onkol. 181:507–514.

    Article  PubMed  Google Scholar 

  • Smith, T. A. 2000. Mammalian hexokinases and their abnormal expression in cancer. Br. J. Biomed. Sci. 57:170–178.

    CAS  PubMed  Google Scholar 

  • Spicer, J. and Ashworth, A. 2004. LKB1 kinase: master and commander of metabolism and polarity. Curr. Biol. 14:R383–R385.

    Article  CAS  PubMed  Google Scholar 

  • Tian, M., Zhang, H., Higuchi, T., Oriuchi, N., Nakasone, Y., Takata, K., Nakajima, N., Mogi, K., Endo, K. 2005. Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imaging. Ann. Nucl. Med. 194:335–338.

    Article  Google Scholar 

  • Vassilev, L. T. 2007. MDM2 inhibitors for cancer therapy. Trends Mol. Med. 13:23–31.

    Article  CAS  PubMed  Google Scholar 

  • Vaziri, H., Dessain, S. K., Ng Eaton, E., Imai, S. I., Frye, R. A., Pandita, T. K., Guarente, L., Weinberg, R. A. 2001. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107:149–159.

    Article  CAS  PubMed  Google Scholar 

  • Veyhl, M., Wagner, K., Volk, C., Gorboulev, V., Baumgarten, K., Weber, W. M., Schaper, M., Bertram, B., Wiessler, M., Koepsell, H. 1998. Transport of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard (D-19575) into tumor cells is mediated by the Na+-D-glucose cotransporter SAAT1. Proc. Natl. Acad. Sci. USA 95:2914–2919.

    Article  CAS  PubMed  Google Scholar 

  • Vogelstein, B., Lane, D. and Levine, A. J. 2000. Surfing the p53 network. Nature 408:307–310.

    Article  CAS  PubMed  Google Scholar 

  • Warburg, O. 1956. On respiratory impairment in cancer cells. Science 124:269–270.

    CAS  PubMed  Google Scholar 

  • Wei, C., Amos, C. I., Stephens, L. C., Campos, I., Deng, J. M., Behringer, R. R., Rashid, A., Frazier, M. L. 2005. Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis. Cancer Res. 65:11297–11303.

    Article  CAS  PubMed  Google Scholar 

  • Wick, A. N., Drury, D. R. and Morita, T. N. 1955. 2-Deoxyglucose; a metabolic block for glucose. Proc. Soc. Exp. Biol. Med. 89:579–582.

    CAS  PubMed  Google Scholar 

  • Wilson, J. E. and Chung, V. 1989. Rat brain hexokinase: further studies on the specificity of the hexose and hexose 6-phosphate binding sites. Arch. Biochem. Biophys. 269:517–525.

    Article  CAS  PubMed  Google Scholar 

  • Wu, C., Okar, D. A., Stoeckman, A. K., Peng, L. J., Herrera, A. H., Herrera, J. E., Towle, H. C., Lange, A. J. 2004. A potential role for fructose-2,6-bisphosphate in the stimulation of hepatic glucokinase gene expression. Endocrinology 145:650–658.

    Article  CAS  PubMed  Google Scholar 

  • Xu, D. and Finkel, T. 2002. A role for mitochondria as potential regulators of cellular life span. Biochem. Biophys. Res. Commun. 294:245–248.

    Article  CAS  PubMed  Google Scholar 

  • Xu, R. H., Pelicano, H., Zhou, Y., Carew, J. S., Feng, L., Bhalla, K. N., Keating, M. J., Huang, P. 2005. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 65:613–621.

    Article  CAS  PubMed  Google Scholar 

  • Yoon, K. A., Nakamura, Y. and Arakawa, H. 2004. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J. Hum. Genet. 49:134–140.

    Article  CAS  PubMed  Google Scholar 

  • Zeng, P. Y. and Berger, S. L. 2006. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation. Cancer Res. 66:10701–10708.

    Article  CAS  PubMed  Google Scholar 

  • Zhou, S., Kachhap, S. and Singh, K. K. 2003. Mitochondrial impairment in p53-deficient human cancer cells. Mutagenesis 18:287–292.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, State University of New York Upstate Medical University, Syracuse, NY, 13210, USA

    Chad A. Corcoran, Ying Huang & M. Saeed Sheikh

Authors
  1. Chad A. Corcoran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ying Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Saeed Sheikh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Saeed Sheikh .

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science + Business Media, LLC

About this chapter

Cite this chapter

Corcoran, C.A., Huang, Y., Sheikh, M.S. (2009). Energy Generating Pathways and the Tumor Suppressor p53. In: Mitochondria and Cancer. Springer, New York, NY. https://doi.org/10.1007/978-0-387-84835-8_8

Download citation

Publish with us

Policies and ethics

Search

Navigation